Royce & Associates LP boosted its holdings in shares of Molina Healthcare, Inc. (NYSE:MOH - Free Report) by 15.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 35,654 shares of the company's stock after purchasing an additional 4,787 shares during the quarter. Royce & Associates LP owned about 0.06% of Molina Healthcare worth $10,377,000 as of its most recent SEC filing.
Other institutional investors have also bought and sold shares of the company. True Wealth Design LLC raised its position in shares of Molina Healthcare by 2,500.0% during the 3rd quarter. True Wealth Design LLC now owns 104 shares of the company's stock valued at $36,000 after buying an additional 100 shares in the last quarter. Versant Capital Management Inc raised its position in Molina Healthcare by 83.1% during the fourth quarter. Versant Capital Management Inc now owns 163 shares of the company's stock valued at $47,000 after purchasing an additional 74 shares during the period. Wingate Wealth Advisors Inc. purchased a new stake in Molina Healthcare during the fourth quarter valued at approximately $52,000. EverSource Wealth Advisors LLC lifted its stake in shares of Molina Healthcare by 81.5% in the 4th quarter. EverSource Wealth Advisors LLC now owns 196 shares of the company's stock valued at $57,000 after purchasing an additional 88 shares during the last quarter. Finally, Financial Perspectives Inc purchased a new position in shares of Molina Healthcare in the 4th quarter worth approximately $59,000. Institutional investors own 98.50% of the company's stock.
Insider Transactions at Molina Healthcare
In other news, Director Steven J. Orlando sold 1,000 shares of Molina Healthcare stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $301.33, for a total value of $301,330.00. Following the transaction, the director now directly owns 17,375 shares in the company, valued at approximately $5,235,608.75. This trade represents a 5.44 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Corporate insiders own 1.10% of the company's stock.
Analyst Upgrades and Downgrades
A number of brokerages recently issued reports on MOH. JPMorgan Chase & Co. restated a "neutral" rating and issued a $350.00 price target (down from $378.00) on shares of Molina Healthcare in a research report on Tuesday, December 17th. Wells Fargo & Company upgraded shares of Molina Healthcare from an "equal weight" rating to an "overweight" rating and raised their target price for the stock from $295.00 to $372.00 in a report on Wednesday, March 5th. UBS Group cut their price target on shares of Molina Healthcare from $374.00 to $325.00 and set a "neutral" rating on the stock in a report on Friday, February 7th. Mizuho decreased their price objective on shares of Molina Healthcare from $382.00 to $376.00 and set an "outperform" rating for the company in a research note on Monday, March 3rd. Finally, Barclays dropped their target price on Molina Healthcare from $372.00 to $339.00 and set an "equal weight" rating for the company in a research report on Friday, February 7th. One research analyst has rated the stock with a sell rating, seven have assigned a hold rating, six have given a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat, the company currently has an average rating of "Hold" and an average target price of $355.69.
View Our Latest Report on Molina Healthcare
Molina Healthcare Stock Down 1.7 %
NYSE MOH traded down $5.42 on Friday, reaching $309.85. 1,046,887 shares of the stock traded hands, compared to its average volume of 610,647. Molina Healthcare, Inc. has a 12 month low of $262.32 and a 12 month high of $423.92. The company has a market cap of $17.20 billion, a price-to-earnings ratio of 15.17, a PEG ratio of 1.06 and a beta of 0.56. The company has a fifty day moving average price of $299.51 and a 200-day moving average price of $309.97. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.62 and a current ratio of 1.62.
Molina Healthcare (NYSE:MOH - Get Free Report) last released its quarterly earnings data on Wednesday, February 5th. The company reported $5.05 earnings per share for the quarter, missing the consensus estimate of $5.74 by ($0.69). Molina Healthcare had a net margin of 2.90% and a return on equity of 28.13%. As a group, research analysts forecast that Molina Healthcare, Inc. will post 24.4 EPS for the current fiscal year.
Molina Healthcare Company Profile
(
Free Report)
Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
Featured Articles

Before you consider Molina Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.
While Molina Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.